Business Description
Crescent Biopharma is a US-based cancer drug development company founded in 2024 and based in Waltham, Massachusetts. Its most advanced drug candidate, CR-001, is currently in Phase 3 clinical trials as a treatment for solid tumors, with two additional candidates, CR-002 and CR-003, also in development. The company works alongside Sichuan Kelun-Biotech to bring new cancer treatments to market.
